BICLUSTER_ID : DNREG-102
PATHOGENS /4/ : pseudomonas aeruginosa,streptococcus pneumoniae,bifidobacterium bifidum,helicobacter pylori
TARGETS /8/ : MCM6, PPIC, NDUFB5, PARP1, BLVRA, HPRT1, IDH1, IARS2
Gene SetLeading Edge Genes
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UPSET, ARL2BP, MAGOH, CETN2, ELOVL6, HPRT1, IARS2, PPIC, GNPAT, HTATSF1, NCBP2, NDUFB5, RPA3, BLVRA, SMC3, SLC9A6, NHP2L1, MSH6, WRB, PDIA6, PARP1, CCT8, IDH1, ZMPSTE24, DDX46, GMFB, CNIH, SSR1, NUP205, RCN2, NRD1
RHODES UNDIFFERENTIATED CANCERMAD2L1, KIF23, CCNB1, CENPA, MCM6, MELK, RPA3, TOP2A
REACTOME DNA REPLICATION PRE INITIATIONMCM6, RPA3, POLE2, ORC2L
GALE APL WITH FLT3 MUTATED UP
BENPORATH MYC MAX TARGETS
SEIDEN MET SIGNALING
KEGG PEROXISOME
MARTINEZ RESPONSE TO TRABECTEDIN
BOYAULT LIVER CANCER SUBCLASS G123 UP
RAMALHO STEMNESS UP
REACTOME CELL CYCLE CHECKPOINTS
GENTILE RESPONSE CLUSTER D3
KUMAMOTO RESPONSE TO NUTLIN 3A DN
REACTOME ELECTRON TRANSPORT CHAIN
NCI PHOSPHORYLATION OF THE APC C
BASSO B LYMPHOCYTE NETWORK
WAKASUGI HAVE ZNF143 BINDING SITES
STEIN ESRRA TARGETS DN
WAESCH ANAPHASE PROMOTING COMPLEX
OUELLET OVARIAN CANCER INVASIVE VS LMP UP
REACTOME PEROXISOMAL LIPID METABOLISM
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN
HAHTOLA MYCOSIS FUNGOIDES CD4 DN
KEGG OOCYTE MEIOSIS
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN
LEE LIVER CANCER SURVIVAL DN
GARY CD5 TARGETS DN
NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A
WANG LMO4 TARGETS UP
LINDGREN BLADDER CANCER WITH LOH IN CHR9Q
ONKEN UVEAL MELANOMA UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
HOSHIDA LIVER CANCER SUBCLASS S2
RICKMAN METASTASIS UP
NCI CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
HAMAI APOPTOSIS VIA TRAIL UP
WEST ADRENOCORTICAL TUMOR UP
GOLDRATH HOMEOSTATIC PROLIFERATION
BOYAULT LIVER CANCER SUBCLASS G23 UP
KEGG MISMATCH REPAIR
STARK PREFRONTAL CORTEX 22Q11 DELETION DN
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DNRFC3, MAD2L1, PDIA6, MSH2, POLE2, RPA3, RFC5, MAGED1, NUP205, RCN2
ZHONG RESPONSE TO AZACITIDINE AND TSA DN
REACTOME G1 S TRANSITION
BLALOCK ALZHEIMERS DISEASE DN
REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX
FAELT B CLL WITH VH REARRANGEMENTS DN
MOREAUX MULTIPLE MYELOMA BY TACI DN
NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX
NCI MITOTIC METAPHASE ANAPHASE TRANSITION
NUYTTEN NIPP1 TARGETS DN
CORUM SNF2H-COHESIN-NURD COMPLEX
REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B
SENESE HDAC3 TARGETS DN
MARTINEZ RESPONSE TO TRABECTEDIN DN
KIM WT1 TARGETS DN
ACEVEDO LIVER CANCER UP
SCIBETTA KDM5B TARGETS DN
KAUFFMANN DNA REPAIR GENES
NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
GEORGES TARGETS OF MIR192 AND MIR215
REACTOME PHOSPHORYLATION OF THE APC
MORI EMU MYC LYMPHOMA BY ONSET TIME UP
TIEN INTESTINE PROBIOTICS 6HR DN
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx2 npgecbifidobacterium bifidumpseudomonas aeruginosastreptococcus pneumoniae d39helicobacter pylori kx1 npgecGeneSet Name
-0.00489 -0.00072 -0.01279 -0.03975 -0.00733ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
-0.00065 -0.00003 -0.02924 -0.05583 -0.00202RHODES_UNDIFFERENTIATED_CANCER
-0.00061 -0.00189 -0.08852 -0.14167 -0.00239REACTOME_DNA_REPLICATION_PRE_INITIATION
-0.01837 -0.01930 -0.02995 -0.00990 -0.04935GALE_APL_WITH_FLT3_MUTATED_UP
-0.00219 -0.01077 -0.08688 -0.00995 -0.01238BENPORATH_MYC_MAX_TARGETS
-0.06040 -0.19425 -0.03042 -0.04882 -0.01530SEIDEN_MET_SIGNALING
-0.04060 -0.17256 -0.17007 -0.08208 -0.01373KEGG_PEROXISOME
-0.05313 -0.05336 -0.00500 -0.04092 -0.01765MARTINEZ_RESPONSE_TO_TRABECTEDIN
-0.06351 -0.05508 -0.01718 -0.06172 -0.10257BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
-0.02836 -0.00314 -0.00090 -0.02514 -0.01531RAMALHO_STEMNESS_UP
-0.00003 -0.00026 -0.00423 -0.18352 -0.00086REACTOME_CELL_CYCLE_CHECKPOINTS
-0.07313 -0.12037 -0.00034 -0.13524 -0.09658GENTILE_RESPONSE_CLUSTER_D3
-0.04464 -0.02902 -0.07193 -0.14912 -0.08108KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.00115 -0.00015 -0.07078 -0.18395 -0.00039REACTOME_ELECTRON_TRANSPORT_CHAIN
-0.00119 -0.02484 -0.09607 -0.18366 -0.00888NCI_PHOSPHORYLATION_OF_THE_APC_C
-0.01977 -0.00224 -0.16721 -0.00490 -0.05536BASSO_B_LYMPHOCYTE_NETWORK
-0.13870 -0.00163 -0.19894 -0.05418 -0.04323WAKASUGI_HAVE_ZNF143_BINDING_SITES
-0.00219 -0.12405 -0.10119 -0.19151 -0.01125STEIN_ESRRA_TARGETS_DN
-0.07316 -0.05837 -0.04714 -0.16916 -0.12614WAESCH_ANAPHASE_PROMOTING_COMPLEX
-0.00338 -0.05713 -0.00029 -0.04351 -0.06498OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
-0.00494 -0.10805 -0.07680 -0.12205 -0.01303REACTOME_PEROXISOMAL_LIPID_METABOLISM
-0.04233 -0.00212 -0.07235 -0.03950 -0.03248MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
-0.02754 -0.00667 -0.02319 -0.01957 -0.01416HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
-0.00681 -0.00459 -0.00045 -0.16292 -0.01163KEGG_OOCYTE_MEIOSIS
-0.05828 -0.16280 -0.11040 -0.08443 -0.02063LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
-0.00657 -0.00053 -0.00284 -0.07780 -0.00959LEE_LIVER_CANCER_SURVIVAL_DN
-0.04586 -0.00390 -0.01258 -0.00609 -0.10908GARY_CD5_TARGETS_DN
-0.01433 -0.01357 -0.01596 -0.12634 -0.01507NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
-0.04610 -0.07241 -0.19470 -0.19334 -0.02619WANG_LMO4_TARGETS_UP
-0.11048 -0.01401 -0.07790 -0.01258 -0.06746LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
-0.03980 -0.04838 -0.18667 -0.05337 -0.02071ONKEN_UVEAL_MELANOMA_UP
-0.04603 -0.02139 -0.00868 -0.15969 -0.03512RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.18921 -0.10293 -0.04741 -0.17175 -0.07057HOSHIDA_LIVER_CANCER_SUBCLASS_S2
-0.09744 -0.06510 -0.00225 -0.03433 -0.05493RICKMAN_METASTASIS_UP
-0.00265 -0.09131 -0.07540 -0.19334 -0.00949NCI_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE
-0.06785 -0.14367 -0.00408 -0.00070 -0.13654HAMAI_APOPTOSIS_VIA_TRAIL_UP
-0.00769 -0.00673 -0.01510 -0.07686 -0.00298WEST_ADRENOCORTICAL_TUMOR_UP
-0.00903 -0.00101 -0.18933 -0.00341 -0.00415GOLDRATH_HOMEOSTATIC_PROLIFERATION
-0.17014 -0.00003 -0.17995 -0.12725 -0.02927BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
-0.02889 -0.00001 -0.13621 -0.16509 -0.06315KEGG_MISMATCH_REPAIR
-0.00430 -0.00785 -0.02880 -0.08271 -0.00086STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
-0.00042 -0.00019 -0.00006 -0.02845 -0.00179CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
-0.01265 -0.00057 -0.10608 -0.16660 -0.03620ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
-0.00214 -0.00002 -0.05329 -0.18500 -0.00298REACTOME_G1_S_TRANSITION
-0.01929 -0.08101 -0.00026 -0.17586 -0.00774BLALOCK_ALZHEIMERS_DISEASE_DN
-0.00281 -0.02271 -0.01134 -0.18558 -0.00671REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX
-0.01320 -0.13671 -0.01766 -0.08185 -0.00762FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
-0.10216 -0.00105 -0.01021 -0.00101 -0.04602MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
-0.00238 -0.02067 -0.01356 -0.18300 -0.00776NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX
-0.15012 -0.05452 -0.12423 -0.06164 -0.08120NCI_MITOTIC_METAPHASE_ANAPHASE_TRANSITION
-0.00740 -0.03076 -0.13346 -0.10034 -0.00278NUYTTEN_NIPP1_TARGETS_DN
-0.04797 -0.08176 -0.03631 -0.08186 -0.17200CORUM_SNF2H-COHESIN-NURD_COMPLEX
-0.00203 -0.02318 -0.03678 -0.14210 -0.00873REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
-0.01982 -0.07778 -0.14639 -0.10248 -0.00236SENESE_HDAC3_TARGETS_DN
-0.12049 -0.00352 -0.00098 -0.04630 -0.07984MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
-0.03111 -0.01291 -0.00054 -0.01958 -0.02271KIM_WT1_TARGETS_DN
-0.00904 -0.09489 -0.00067 -0.01849 -0.01628ACEVEDO_LIVER_CANCER_UP
-0.00149 -0.00001 -0.02302 -0.01880 -0.00090SCIBETTA_KDM5B_TARGETS_DN
-0.09101 -0.00001 -0.04560 -0.01600 -0.06811KAUFFMANN_DNA_REPAIR_GENES
-0.00014 -0.00242 -0.01943 -0.12200 -0.00012NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE
-0.02831 -0.03758 -0.01016 -0.00046 -0.02663GEORGES_TARGETS_OF_MIR192_AND_MIR215
-0.00137 -0.02560 -0.09563 -0.15183 -0.01002REACTOME_PHOSPHORYLATION_OF_THE_APC
-0.09503 -0.00150 -0.04215 -0.00067 -0.09524MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
-0.02017 -0.05793 -0.00052 -0.02518 -0.02084TIEN_INTESTINE_PROBIOTICS_6HR_DN